- $1.62bn
- $1.67bn
- $467.64m
- 82
- 32
- 93
- 79
Annual income statement for Maxlinear, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 892 | 1,120 | 693 | 361 | 468 |
| Cost of Revenue | |||||
| Gross Profit | 496 | 650 | 386 | 195 | 266 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 832 | 940 | 731 | 584 | 595 |
| Operating Profit | 60 | 180 | -38.2 | -223 | -127 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 47.9 | 174 | -63.8 | -239 | -141 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 42 | 125 | -73.1 | -245 | -137 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 42 | 125 | -73.1 | -245 | -137 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 42 | 125 | -73.1 | -245 | -137 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.608 | 1.59 | -0.727 | -2.51 | -1.39 |